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ABSTRACT 
Background: Inadequate pain management after cardiac surgery may result 
in increased morbidity and length of hospital stay. Although opioids are the 
mainstay of postoperative analgesia, nonsteroidal anti-inflammatory drugs 
(NSAIDs) may be used instead to avoid the adverse effects (AEs) associated 
with opioids. Lornoxicam is a newly developed NSAID, the use of which is 
increasing. However, lornoxicam has not been studied for use in pain manage- 
ment after cardiac surgery. 
Objective: The objective of this study was to compare the efficacy and tol- 
erability of lornoxicam and diclofenac sodium, an NSAID well established for 
use in pain management after major surgery, in pain management after coro- 
nary artery bypass grafting (CABG). 
Methods: This single-blind, randomized, active-controlled study was con- 
ducted at the Gaziantep University Hospital, Gaziantep, Turkey. Adult patients 
scheduled to undergo valve or CABG surgery for the first time were included. 
Patients were premedicated with diazepam l0 mg PO at 10 PM on the evening 
before surgery. General anesthesia was induced using fentanyl, midazolam, and 
propofol, and maintained using fentanyl and isoflurane in pure oxygen. After 
extubation and when they stated that they felt pain, patients were randomly 
assigned to 1 of 2 treatment groups: lornoxicam 8 mg IM q8h or diclofenac 75 mg 
IM ql2h, for 48 hours. Meperidine 1mg/kg IM was given for additional analgesia 
when needed (rescue medication). Pain relief was assessed using an 11-point vis- 
ual analog scale (0 = no pain to 10 -- worst pain imaginable) immediately before the 
first injection (baseline), and at 15 and 30 minutes and 1, 2, 3, 4, 6, 12, 18, 24, and 
48 hours after the first injection. Sedation was assessed using a 5-point scale (0 = 
awake and alert to 4 = deep sedation) at the same time points. Tolerability was as- 
sessed by monitoring of AEs using patient interview and laboratory analyses. 
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Results: Forty patients were enrolled in the study (30 men, 10 women; 
mean [SD] age, 54.4 [11.1] years; 20 patients per treatment group). The demo- 
graphic and clinical characteristics and mean baseline pain relief scores were 
statistically similar between the 2 treatment groups. The mean pain relief 
scores at 15 and 30 minutes were statistically similar to baseline values in the 
2 treatment groups. However, the mean pain relief scores at ->1 hour after the 
first injection were significantly lower compared with baseline values (both 
groups, P < 0.05 at time points >1 hour). No significant between-group differ- 
ences in mean pain relief scores were found at any time point. The overall 
mean pain relief scores were statistically similar between the 2 treatment 
groups. The mean sedation scores were significantly higher at 30 minutes, 
1 hour, and 2 hours after the first injection in the diclofenac group compared 
with the lornoxicam group (all, P < 0.05). No AEs were observed. The need for 
rescue medication was statistically similar between the 2 treatment groups 
(lornoxicam, 2 patients; diclofenac, 3 patients). 
Conclusions: In this study of adult patients who underwent CABG, the effi- 
cacy of lornoxicam and diclofenac were similar in postoperative pain manage- 
ment. Both study drugs were well tolerated. (Curt Ther Res Clin Exp. 2005;66: 
107-116) Copyright © 2005 Excerpta Medica, Inc. 
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INTRODUCTION 
Inadequate pain management after cardiac surgery may result in increased 
morbidity and length of hospital stay. 1-3 Postoperative analgesia may facili- 
tate the resumption of activities of daily living, including ambulation, deep 
breathing, and effective coughing. 40pioids are the mainstay of pain man- 
agement after major surgical procedures. However, their use may lead 
to adverse effects (AEs) (eg, respiratory depression, sedation, nausea, and 
constipation). 5,6 Nonsteroidal anti-inflammatory drugs (NSAIDs) may be 
used for postoperative pain management to avoid the AEs associated with 
opioids. 7
Lornoxicam is an NSAID developed -7 years ago. 8 It has pharmacokinetic 
and pharmacodynamic properties imilar to those of the often-used rug 
piroxicam. It has been shown to be as effective as morphine, pethidine 
(meperidine), and tramadol in managing pain after several types of major 
surgery (eg, lumbar disk surgery, dental surgery, hysterectomy). 8-11 However, 
based on a MEDLINE search (key terms: lornoxicam, cardiac surgery, and post- 
operative pain control; years: 1960-2004), lornoxicam has not been studied 
for use in pain management after cardiac surgery. Thus, the aim of the present 
study was to compare the efficacy and tolerability of lornoxicam and di- 
clofenac sodium (an NSAID with a good safety profile well established for use 
in pain management after major surgery 7,12,13) in pain management after valve 
or coronary artery bypass grafting (CABG) surgery. 
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PATIENTS AND METHODS 
This single-blind, randomized, active-controlled study was conducted at the 
Gaziantep University Hospital, Gaziantep, Turkey. Approval of the study protocol 
was obtained from the ethics committee at the hospital. Written informed con- 
sent was obtained from each eligible patient before the study. 
Inclusion and Exclusion Criteria 
Patients aged 18 to 65 years scheduled to undergo valve or CABG surgery for 
the first time using a pump oxygenator were eligible for the study. 
Patients were excluded if they had hepatic or renal disease, diabetes mellitus, 
cancer, and/or were receiving oral contraceptives. 
Surgical Procedures 
Patients were admitted to the hospital on the night before surgery and were 
premedicated with diazepam 10 mg PO at 10 PM on the evening before surgery. 
Patients were monitored using electrocardiography, pulse oximetry, and arteri- 
al and central venous catheterization. Anesthesia was induced using IV admin- 
istration of fentanyl 2 IJg/kg, midazolam 0.02 to 0.05 mg/kg, and propofol 1 to 
2 mg/kg, and maintained using fentanyl 0.1 tJg/kg • min IV and inhalational isoflu- 
rane 0.6% to 1.0% in pure oxygen. Neuromuscular blockade was achieved using 
vecuronium bromide 0.1 mg/kg IV and maintained using IV infusions of vecuro- 
nium bromide bolus 0.03 mg/kg at 30-minute intervals. All surgical procedures 
were performed through a full median sternotomy by the same surgical team in 
each patient. 
After surgery, while in the intensive care unit (ICU), patients underwent 
mechanical ventilation and were switched to synchronized intermittent 
mandatory ventilation plus pressure support. Patients were extubated when 
they were hemodynamically stabile, cooperative, without excessive chest 
tube drainage, and fulfilled the extubation criteria (negative inspiratory force, 
>-20 cm H20; arterial carbon dioxide tension, <45 mm Hg; fraction of inspired 
oxygen, <0.5%; pH, >7.30). The extubation time was recorded in each patient. 
Administration of Study Medication 
After extubation and when they stated that they felt pain, patients were ran- 
domly assigned, using a computer-generated table of random numbers, to 1 of 
2 treatment groups: lornoxicam 8 mg IM q8h or diclofenac 75 mg IM q12h, for 
48 hours. The study investigators were blinded to the administration schedules 
of the 2 study drugs. Meperidine 1mg/kg IM was given for additional analgesia 
in cases of inadequate pain relief (rescue medication). 
Efficacy Assessment 
Pain relief and sedation were assessed by the physician responsible for post- 
operative care of the patients, immediately before the first injection of study med- 
ication (baseline; time 0) and at 15 and 30 minutes and 1, 2, 3, 4, 6, 12, 18, 24, and 
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48 hours after the first injection. Pain relief was assessed using an 11-point 
visual analog scale (VAS) (0 = no pain to 10 = worst pain imaginable). Sedation 
was assessed using a 5-point scale 14,15 (0 = awake and alert to 4 -- deep sedation). 
Tolerability Assessment 
AEs (eg, gastric discomfort, nausea, vomiting, hypotension, bradycardia, 
renal impairment) were monitored throughout the study using patient inter- 
view and laboratory analyses. Nausea was to be treated using metoclopramide 
10 mg IV. Bleeding at the operative site was assessed using visualization 
through a chest tube each hour for 72 hours after surgery. 
Statistical Analysis 
Statistical analyses were performed using SPSS version 10.0 (SPSS Inc., 
Chicago, Illinois). Results are presented as mean (SD). The chi-square test and 
the Fisher exact test were used to compare occurrences between the 2 treat- 
ment groups. The unpaired Student  test was used to compare measured ata 
(VAS or sedation score) between the 2 groups. A P value <0.05 was considered 
statistically significant. 
RESULTS 
Forty patients were enrolled in the study (30 men, 10 women; mean [SD] age, 
54.4 [11.1] years; 20 patients per treatment group). The demographic and clini- 
cal characteristics of the study patients were statistically similar between the 
2 treatment groups (Table I). 
Table I. Demographic and clinical characteristics of the study population 
(N = 40).* Data are mean (SD) unless otherwise noted. 
Lornoxicam Diclofenac 
Characteristic (n = 20) (n = 20) 
Age, y 53.3 (12.2) 55.7 (10.3) 
Sex, no. of patients 
Male 14 16 
Female 6 4 
Type of surgery, no. of patients 
CABG 16 17 
Valve 4 3 
Duration of surgery, h 4.46 (0.32) 4.23 (0.28) 
CPB time, min 95 (25) 110 (34) 
Extubation time, rain 224 (34) 216 (24) 
Chest tube drainage, mL/24 h 420 (50) 460 (70) 
CABG = coronary artery bypass grafting; CPB -- cardiopulmonary bypass. 
*No significant between-group differences were found. 
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Efficacy 
The baseline mean pain relief scores were statistically similar between the 2 
groups (Figure). The mean (SD) extubation times were 224 (34) and 216 (24) min- 
utes in the lornoxicam and diclofenac groups, respectively. The lornoxicam 
group received the first dose of study medication at 108 (26) minutes (mean 
[SD]) after extubation, and the diclofenac group, at 96 (12) minutes (mean [SD]) 
after extubation. The mean pain relief scores at 15 and 30 minutes after the first 
injection of study medication were statistically similar to baseline values in the 
2 treatment groups (Table II). At _>1 hour after the first injection in the 2 treat- 
ment groups, the mean pain relief scores were significantly lower compared 
with baseline values (nearly zero at 48 hours) (both groups, P < 0.05 at time 
points _>1 hour). The pain relief scores were statistically similar between the 
2 groups at all time points (Table ll). 
In the diclofenac group, the mean sedation scores were significantly higher 
at 30 minutes, 1hour, and 2 hours after the first injection compared with those 
in the lornoxicam group (Table II) (all, P < 0.05). 
Tolerabil ity 
None of the patients receiving either study drug experienced gastric discom- 
fort, nausea, vomiting, hypotension, bradycardia, or renal damage (Table III). 
Two patients in the ]ornoxicam group and 3 patients in the diclofenac group 
required rescue medication. The mean (SD) additional analgesia times were 
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Figure. Mean (SD) pain relief scores in the study popu lat ion  (N = 40). Pain relief was 
assessed using an 11-point visual analog scale (0 = no pain to 10--worst pain 
imaginable) .  *P < 0.05 versus prein ject ion (0 min) .  
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Table II. Mean (SD) pain relief* and sedation t scores in the study population (N = 40). 
Lornoxicam Diclofenac 
(n = 20) (n = 20) 
Pain Relief Sedation Pain Relief Sedation 
Time Point Score Score Score Score 
Before injection 
(baseline) 5.35 (0.98) 3.78 (2.10) 5.15 (2.85) 4.75 (3.00) 
After injection 
15 min 6.25 (1.68) 2.00 (0.67) 6.12 (2.41) 2.00 (0.64) 
30 min 5.25 (1.99) 0.41 (0.09) 5.10 (2.42) 1.90 (0.71) ~ 
1 h 3.70 (2.25) § 0.60 (0.1 3) 3.72 (2.30) § 1.25 (0.78)~ 
2 h 2.55 (2.37)§ 0.51 (0.11) 3.47 (2.35) § 1.1 0 (0.91)~ 
3 h 0.25 (0.78) § 0.41 (0.09) 3.45 (3.15) § 0.75 (0.55) 
4 h 0.10 (0.44) § 0.44 (0.10) 2.55 (2.43) § 0.70 (0.57) 
6 h 1.10 (0.65) § 0.52 (0.11) 2.60 (1.75)§ 0.25 (0.44) 
12 h 2.65 (2.10) § 0.58 (0.1 3) 3.25 (2.90)§ 0.90 (1.97) 
18 h 0.65 (1.72)§ 0.22 (0.05) 1.95 (0.90) § 0.20 (0.41) 
24 h 1.67 (1.43) § 0.00 (0.00) 1.25 (0.86) § 0.05 (0.22) 
48 h 1.23 (0.33) § 0.00 (0.00) 1.10 (0.30)§ 0.00 (0.00) 
*Pain relief was assessed using an 11-point visual analog scale (0 = no pain to 10 = worst pain 
imaginable). 
t Sedation was assessed using a 5-point scale (0 = awake and alert to 4 = deep sedation). 
P < 0.05 versus Iornoxicam group. 
§ P < 0.05 versus baseline. 
Table III. Hemodynamic properties of the study population (N = 40).* Data are mean 
(SD). 
Lornoxicam Diclofenac 
(n = 20) (n = 20) 
Before 24 h Before 24 h 
Property Surgery After Surgery Surgery After Surgery 
Hb, mmol/L 10.5 (0.9) 7.5 (1.1) 11.2 (2.9) 7.1 (0.7) 
Hematocrit, % 36.2 (1.6) 31.7 (2.6) 35.8 (2.4) 30.7 (2.6) 
SCC, IJmol/L 1.1 (0.1) 1.2 (0.9) 0.8 (0.2) 1.4 (0.7) 
Platelet count, cells x 109/L 222 (59) 164 (36) 234 (65) 158 (42) 
INR 1.2 (0.1) 1.6 (0.3) 1.1 (0.2) 1.4 (0.4) 
Hb = hemoglobin concentration; SCC = serum creatinine concentration; INR = international normal- 
ized ratio. 
*No significant between-group differences were found. 
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5.9 (0.4) hours in the lornoxicam group and 5.2 (0.3) hours in the diclofenac 
group. No significant between-group differences were found in the prevalence 
of bleeding at the operative site (Table I), and none of the patients required 
repeat surgery during the study period. 
DISCUSSION 
Opioids are frequently used for pain management after cardiac surgery, with 
morphine being most commonly prescribed. 16In 1 study, lornoxicam was found 
to be as effective as morphine in total pain relief after microsurgical lumbar disk 
surgery. 8 Our study compared lornoxicam with diclofenac, and the results sug- 
gest that the 2 drugs have similar analgesic efficacy. 
The analgesic efficacy and tolerability of lornoxicam, at differing doses and 
routes of administration, have been compared with other analgesics in previous 
studies. 17-23 Hein et a] 17 compared the analgesic effects of lornoxicam 8 mg PO 
with those of paracetamol 1 g PO after gynecologic surgery and found similar, sat- 
isfactory analgesia with both study drugs. Thienthong et a118 studied lornoxicam 
16 mg IV in patients undergoing spinal surgery and found adequate pain relief 
2 hours postoperatively. In another study, Trampitsch et a119 reported that lornoxi- 
cam 8 mg IV was associated with improved quality of analgesia fter gynecologic 
surgery compared with controls. Based on our literature search, no studies have 
compared the doses and effects of lornoxicam and diclofenac. However, studies 
comparing the effects of diclofenac with those of other analgesics in patients 
undergoing surgeries other than cardiac surgery have shown diclofenac 75 to 
100 mg administered 2 to 4 times daily to be effective. 2°,23 Although lornoxicam 
and diclofenac are not equipotent, the doses used in the present study have been 
found to be effective for postoperative analgesia in various types of surgery. 
Opioids have been associated with AEs (eg, respiratory depression, seda- 
tion, nausea, and constipation). For example, the sedation frequently seen with 
the use of opioids may cause delayed extubation, delayed and/or restricted 
ambulation, and increased length of stay in the ICU. 5,24 For this reason, some 
investigators have suggested substituting opioids with other drug classes, such 
as NSAIDs, in postoperative pain control. 7,25 However, NSAIDs also have been 
associated with serious AEs (eg, hypotension, bradycardia, gastric discomfort, 
renal damage, nausea nd vomiting, bleeding disorders). In fact, Griffin 26 con- 
cluded that NSAIDs should not be used routinely in cardiac surgery because of 
these AEs. For example, NSAIDs inhibit prostaglandin synthesis, which may result 
in impaired platelet function and, hence, bleeding at the surgical site. However, 
because NSAIDs inhibit cyclooxygenase action to differing extents, their anti- 
platelet action differs. 27 Based on the literature search, the present study is the 
first to compare the effects of lornoxicam and diclofenac in cardiac surgery. 
Thus, the effects of these 2 drugs on operative-site bleeding in cardiac surgery 
have not been reported. However, the effects of various NSAIDs have been com- 
pared in various surgeries other than cardiac surgery (eg, tonsillectomy), and 
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the need for repeat surgery due to bleeding at the operative site has been found 
to be greater with NSAIDs compared with controls. 28 In the study by Hein et al, 17 
lornoxicam was associated with better pain relief compared with paracetamol 
in gynecologic surgery, and no significant between-group difference was found 
in the prevalence of operative-site bleeding. Niemi et a127 reported reversible 
platelet dysfunction with long-term diclofenac use in healthy volunteers. In the 
present study, no serious postoperat ive bleeding was found with either NSAID. 
Although the mean sedation score was higher in the diclofenac group com- 
pared with the lornoxicam group at 30 minutes, 1 hour, and 2 hours after the 
first injection of study medication (all, P < 0.05), all sedation scores in both 
groups were <3 (easy to wake up when slightly shaken). 
Study Limitations 
The number of patients in the present study was fairly small. Furthermore, this 
study had a single-blind esign. Future studies with larger sample sizes and using 
additional comparator drugs and a double-blind esign are necessary to investi- 
gate the effectiveness of these drugs in relieving pain after cardiac surgery. 
CONCLUSIONS 
This comparison of the effects of lornoxicam and diclofenac in adults undergoing 
CABG suggests that pain after cardiac surgery may be controlled with either 
drug. Both study drugs were well tolerated. 
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